CLINICAL GUIDELINES OF RUSSIAN RESPIRATORY SOCIETY: ALGORITHM FOR THE MANAGEMENT OF PATIENTS WITH COPD


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

By the end of 2016, Expert council of the Russian respiratory society has prepared a new edition of the Federal clinical guidelines, and algorithm of management of patient with established COPD diagnosis became an important its part. This algorithm reflects the current views of the differentiated approach to the management of patients with COPD. In recent years, the effectiveness of a number of new drugs and their combinations, as well as a fundamentally new class of biological molecules for the treatment of COPD has been intensively studied. In the near future, aff of this wiff certainly have an impact on our current ideas about the differentiated approach to the treatment and open up new opportunities for more individualized treatment of patients with COPD.

全文:

受限制的访问

作者简介

Sergey AVDEEV

Email: pulmo_fmba@mail.ru
corresponding member of RAS, MD, professor deputy director Scientific research institute of pulmonology 105077, Moscow, 32 11th Parkovaya St

Zaurbek AYSANOV

MD, professor, Department of pulmonology, Faculty of additional professional education, N.I. Pirogov Russian national research medical university 105077, Moscow, 32 11th Parkovaya St

Andrey BELEVSKY

MD, professor, head of the Department of pulmonology, Faculty of additional professional education, N.I. Pirogov Russian national research medical university 105077, Moscow, 32 11th Parkovaya St

参考

  1. Хроническая обструктивная болезнь легких. Клинические рекомендации. 2016. 69 с. http://spulmo.ru/obrazovatelnye-resursy/ federalnye-klinicheskie-rekomendatsii/ [Chronic obstructive pulmonary disease. Clinical guidelines. 2016. 69 p. (in Russ.)]
  2. Требования к оформлению клинических рекомендаций для размещения в Рубрикаторе. Министерство здравоохранения РФ. М., 2016. 18 с. [Requirements for registration of clinical recommendations for placement in the Categories. Ministry of healthcare of the Russian Federation. Moscow, 2016. 18 p. (in Russ.)]
  3. Jones P.W., Brusselle G., Dal Negro R.W., Ferrer M., Kardos P., Levy M.L., Perez T., Soler Cataluna J.J., van der Molen T., Adamek L., Banik N. Patient-centered assessment of COPD in primary care: experience from a cross-sectional study of health-related quality of life in Europe. Prim. Care Respir. J. 2012;21(3):329-36.
  4. White P., Thorntoh H., Pinnock H., Georgopoulou S., Booth H.P. Overtreatment of COPD with inhaled corticosteroids - implications for safety and costs: cross-sectional observational study. PLoS ONE. 2013;8:e75221.
  5. Rossi A., Guerriero M., Corrado A. OPTIMO/AIPO Study Group. Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO). Respir. Res. 2014;15:77.
  6. Magnussen H., Disse B., Rodriguez-Roisin R., Kirsten A., Watz H., Tetzlaff K., Towse L., Finnigan H., Dahl R., Decramer M., Chanez P., Wouters E.F., Calverley P.M. Withdrawal of inhaled glucocorticoids and exacerbations of COPD. N. Engl. J. Med. 2014;371(14):1285-94.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2017
##common.cookie##